| Literature DB >> 25263463 |
Aloysious Aravinthan1, Benjamin Challis2, Nicholas Shannon3, Matthew Hoare4, Judith Heaney5, Graeme J M Alexander6.
Abstract
Insulin resistance has been described in association with chronic liver disease for decades. Hepatocyte senescence has been demonstrated in chronic liver disease and as many as 80% of hepatocytes show a senescent phenotype in advanced liver disease. The aim of this study was to understand the role of hepatocyte senescence in the development of insulin resistance. Senescence was induced in HepG2 cells via oxidative stress. The insulin metabolic pathway was studied in control and senescent cells following insulin stimulation. GLUT2 and GLUT4 expressions were studied in HepG2 cells and human liver tissue. Further, GLUT2 and GLUT4 expressions were studied in three independent chronic liver disease cohorts. Signalling impairment distal to Akt in phosphorylation of AS160 and FoxO1 was evident in senescent HepG2 cells. Persistent nuclear localisation of FoxO1 was demonstrated in senescent cells despite insulin stimulation. Increased GLUT4 and decreased GLUT2 expressions were evident in senescent cells, human cirrhotic liver tissue and publically available liver disease datasets. Changes in GLUT expressions were associated with a poor clinical prognosis. In conclusion, selective insulin resistance is evident in senescent HepG2 cells and changes in GLUT expressions can be used as surrogate markers of hepatocyte senescence.Entities:
Keywords: Chronic liver disease; Hepatocyte senescence; Selective insulin resistance
Mesh：
Substances：
Year: 2014 PMID： 25263463 DOI： 10.1016/j.yexcr.2014.09.025
Source DB: PubMed Journal: Exp Cell Res ISSN： 0014-4827 Impact factor: 3.905